Electroconvulsive therapy in treatment-resistant schizophrenia: Prediction of response and the nature of symptomatic improvement

Journal of ECT

Volumn 26, Issue 4, 2010, Pages 289-298

  Chanpattana, Worrawat ^a   Sackeim, Harold A ^b,c  

^a Samitivej Srinakarin Hospital   (Thailand)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

antipsychotic medication; electroconvulsive therapy (ECT); prognosis; sex differences; symptoms; treatment resistant schizophrenia

Indexed keywords

DIAZEPAM; FLUPENTIXOL; TRIHEXYPHENIDYL;

ADULT; ANXIETY; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISORIENTATION; ELECTROCONVULSIVE THERAPY; EXCITEMENT; FEMALE; GESTURE; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR RETARDATION; PROSPECTIVE STUDY; SCHIZOPHRENIA; SEX DIFFERENCE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; COMBINED MODALITY THERAPY; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 78650367938     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181cb5e0f     Document Type: Article

References (59)

1. Cerletti U, Bini L. Un neuvo metodo di shockterapie BL'elettro-shock.[ Bolletino Accademia Medica Roma. 1938;64:136-138.
2. Fink M, Sackeim HA. Convulsive therapy in schizophrenia? Schizophr Bull. 1996;22:7-39.
3. Thompson JW, Blaine JD. Use of ECT in the United States in 1975 and 1980. Am J Psychiatry. 1987;144:557-562.
4. Pippard J, Ellam L. Electroconvulsive Treatment in Great Britain, 1980. London, UK: Gaskell; 1981.
5. Martin BA, Kramer PM, Day D, et al. The Clarke Institute experience with electroconvulsive therapy: II. Treatment evaluation and standards of practice. Can J Psychiatry. 1984;29:652-657.
6. Latey R, Fahy T. Electroconvulsive therapy in the Republic of Ireland 1982: a summary of findings. Br J Psychiatry. 1985;147:438-439.
7. Malla A. An epidemiological study of electroconvulsive therapy: rate and diagnosis. Can J Psychiatry. 1986;31:824-830.
8. Baudis P. Elektrokonvulsivni lecba v Ceske republice v letech 1981-1989. Cesk Psychiatr. 1992;88:41-47.
9. Chanpattana W, Kramer BA. Electroconvulsive therapy practice in Thailand. J ECT. 2004;20:94-98.
10. Gazdag G, Kocsis N, Lipcsey A. Rates of electroconvulsive therapy use in Hungary in 2002. J ECT. 2004;20:42-44.
11. Chanpattana W, Kunigiri G, Kramer BA, et al. Survey of ECT practice in teaching hospitals in India. J ECT. 2005;21:100-104.
12. Chanpattana W, Kojima K, Kramer BA, et al. ECT practice in Japan. J ECT. 2005;21:139-144.
13. Chanpattana W, Kramer BA, Kunigiri G, et al. A survey of the practice of electroconvulsive therapy in Asia. J ECT. 2010;26(1):5-10.
14. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2005;(2): CD000076.
15. Dodwell D, Goldberg D. A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms. Br J Psychiatry. 1989;154:635-639.
16. Chanpattana W, Chakrabhand S. Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome. Psychiatry Res. 2001;105:107-115.
17. Chanpattana W, Chakrabhand S, Kongsakon R, et al. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia. J ECT. 1999;15:129-139.
18. Chanpattana W, Chakrabhand S, Sackeim HA, et al. Continuation ECT in treatment-resistant schizophrenia: a controlled study. J ECT. 1999;15:178-192.
19. Chanpattana W, Chakrabhand S, Techakasem P, et al. The use of stabilization period in ECT research in schizophrenia: II. Implementation. J Med Assoc Thai. 1999;82:558-568.
20. Chanpattana W, Chakrabhand S, Kitaroonchai W, et al. Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia. J Med Assoc Thai. 1999;82:477-483.
21. Chanpattana W, Buppanharun W, Chakrabhand S, et al. Effects of stimulus intensity on the efficacy of bilateral ECT in schizophrenia: a preliminary study. Biol Psychiatry. 2000;48:222-228.
22. Chanpattana W. Maintenance ECT in treatment-resistant schizophrenia. J Med Assoc Thai. 2000;83:657-662.
23. Albus M, Scherer J, Hueber S, et al. The impact of familial loading on gender differences in age at onset of schizophrenia. Acta Psychiatr Scand. 1994;89:132-134.
24. Tamminga CA. Gender and schizophrenia. J Clin Psychiatry. 1997;58(suppl 15):33-37.
25. McGlashan TH, Bardenstein KK. Gender differences in affective, schizoaffective, and schizophrenic disorders. Schizophr Bull. 1990;16:319-329.
26. Torgalsboen AK. Full recovery from schizophrenia: the prognostic role of premorbid adjustment, symptoms at first admission, precipitating events and gender. Psychiatry Res. 1999;88:143-152.
27. Lewine R, Haden C, Caudle J, et al. Sex-onset effects on neuropsychological function in schizophrenia. Schizophr Bull. 1997;23:51-61.
28. Salem JE, Kring AM. The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia. Clin Psychol Rev. 1998;18:795-819.
29. Scheller-Gilkey G, Lewine RR. Age at onset and sex differences in corpus callosum area in schizophrenia. Schizophr Res. 1999; 40:229-235.
30. Szymanski S, Lieberman JA, Alvir JM, et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry. 1995; 152:698-703.
31. Szymanski S, Lieberman JA, Pollack S, et al. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics. Biol Psychiatry. 1996;39:249-254.
32. McGlashan TH. A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull. 1988; 14:515-542.
33. Sackeim HA. Electroconvulsive therapy and schizophrenia. In: Hirsch SR, Weinberger D, eds. Schizophrenia. 2nd ed. Oxford, UK: Blackwell; 2003:517-551.
34. Kane JM, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789-796.
35. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
36. Overall JF, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812.
37. Sackeim HA, Decina P, Prohovnik I, et al. Seizure threshold in electroconvulsive therapy: effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry. 1987;44:355-360.
38. Woerner MG, Mannuzza S, Kane JM. Anchoring the BPRS: an aid to improved reliability. Psychopharm Bull. 1988;24:112-117.
39. Folstein M, Folstein S, McHugh P. BMiniYMental State[, a practical method of grading the cognitive state of patients for clinician. Psychiatry Res. 1975;12:189-198.
40. Marder SR, Davis JM, Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry. 1997;58:538-546.
41. Kane JM. Pharmacologic treatment of schizophrenia. Biol Psychiatry. 1999;46:1396-1408.
42. Wirshing DA, Marshall BD, Green MF, et al. Risperidone in treatment-refractory schizophrenia. Am J Psychiatry. 1999;156: 1374-1379.
43. Kalinowsky L, Worthing HJ. Results with electric convulsive in 200 cases of schizophrenia. Psychiatr Q. 1943;17:144-153.
44. Herzberg F. Prognostic variables for electro-shock therapy. J Gen Psychol. 1954;50:79-86.
45. American Psychiatric Association. The Practice of ECT: Recommendations for Treatment, Training and Privileging. 2nd ed. Washington, DC: American Psychiatric Press; 2001:5-25.
46. Fava M, Davidson RG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996; 19:179-200.
47. Flint AJ, Rifat SL. The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord. 1996;36:95-105.
48. Leff JP, Wing JK. Trial of maintenance therapy in schizophrenia. BMJ. 1971;3:599-604.
49. World Health Organization. Schizophrenia: An International Follow-up Study. New York, NY: John Wiley & Sons, 1979.
50. Watt DC, Katz K, Shepherd M. The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychol Med. 1983;13:663-670.
51. National Institutes of Health. Consensus conference: electroconvulsive therapy. JAMA. 1985;254:269-273.
52. American Psychiatric Association. The Practice of ECT: Recommendations for Treatment, Training and Privileging. 1st ed. Washington, DC: American Psychiatric Press; 1990.
53. Royal College of Psychiatrists. The ECT Handbook: The Second Report of the Royal College of Psychiatrists' Special Committee on ECT. London: Gaskell, 1995.
54. Fear CF. The use of ECT in the treatment of schizophrenia and catatonia. In: Scott AIF, ed. The ECT Handbook. The Third Report of the Royal College of Psychiatrists' Special Committee on ECT. Council Report CR128. 2nd ed. Glasgow, UK; Bell & Bain Limited; 2005:30-46.
55. Buchanan RW, Breier A, Kirkpatrick B, et al. Positive and negative symptoms response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry. 1998; 155:751-760.
56. Rosenheck R, Dunn L, Peszke M, et al. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Am J Psychiatry. 1999;156:88-93.
57. Goswami U, Dutta S, Kuruvilla K, et al. Electroconvulsive therapy in neuroleptic-induced parkinsonism. Biol Psychiatry. 1989; 26:234-238.
58. Chanpattana W. Maintenance ECT in schizophrenia: a pilot study. J Med Assoc Thai. 1998;81:17-24.
59. Chanpattana W. The use of stabilization period in ECT research in schizophrenia: I. A pilot study. J Med Assoc Thai. 1999;82:1193-1199.